US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Hematology is the branch of medicine which deals with the study, diagnosis, and treatment of blood-related disorders. Hematology instruments are the diagnostic tools that analyze blood. They are used in testing, counting, measuring and analyzing red blood cells, WBC and platelets. Hematology instruments have evolved rapidly in recent years and many traditional tools were replaced by automated instruments which provide fast and accurate results. Automation is a growing trend in this market. The market is shifting from manual testing to semi-automated analyzers to fully automated analyzers. The global Hematology Analyzers market is anticipated to reach USD$ 1789.23 million by 2021, expanding at a CAGR of 5.7% between 2017 and 2021. Leading players in the global hematology analyzer market are introducing innovative products in order to retain as well as increase their market share. Advancements in information technology has garnered demand for IT-driven medical information networks in healthcare sector, contributing to effective collection and analysis of hematology test data. Such factors are propelling demand for hematology analyzers globally. In 2015, the large capital equipment hematology analyzers segment dominated the market and accounted for more than 49% of the overall revenue market. Large capital equipment hematology analyzers are large automated integrated systems that combine all forms of sample processing, analysis, and presentation of results. These systems are controlled by the laboratory information management system to generate a high-throughput analysis of the sample. Moreover, these systems help laboratories generate results in a faster turnaround time, thereby improving the efficiency and labor utilization. As of 2016, North America holds the largest share of the global market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR of 7.1% from 2016 to 2021. A number of factors including developing healthcare infrastructure, large patient population, increasing funding/investment toward the development of hematology products, and growing focus of both international and domestic players on the Asia-Pacific countries are stimulating the growth of the market in the Asia-Pacific region. Key market players in the hematology analyzers market include Abbott Laboratories, Beckman Coulter, HORIBA Ltd, Siemens AG, Sysmex Corporation, Nihon Kohden Corporation, Bio-Rad Laboratories, Bio-Rad Laboratories, Mindray Medical International Ltd., Roche Diagnostics, and Boule Diagnostics AB. Hematology Analyzers Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). The report firstly introduced the Hematology Analyzers basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
Table of Contents Part I Hematology Analyzers Industry Overview Chapter One Hematology Analyzers Industry Overview 1.1 Hematology Analyzers Definition 1.2 Hematology Analyzers Classification Analysis 1.2.1 Hematology Analyzers Main Classification Analysis 1.2.2 Hematology Analyzers Main Classification Share Analysis 1.3 Hematology Analyzers Application Analysis 1.3.1 Hematology Analyzers Main Application Analysis 1.3.2 Hematology Analyzers Main Application Share Analysis 1.4 Hematology Analyze | read more...